Skip to contentC
Chemed Corp
C
CHEChemed Corp Q1 2013 · 10-Q
Revenue$366.64M$366.64M+3.9% vs Q1 2012 Net Income$22.28M$22.28M+9.0% vs Q1 2012 EPS Diluted$1.17$1.17+10.4% vs Q1 2012 Operating Income$38,852,000+11.1% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Chemed Corp · CIK 19584 · Engraved from SEC EDGAR
Free Cash Flowderived$2,735,000N/M Margins · derivedOperating margin10.6%+0.7 pt vs Q1 2012
Net margin6.1%+0.3 pt vs Q1 2012
ended Mar 31, 2013 · filed Apr 26, 2013 · 26 d after period end